Literature DB >> 26082884

Nanotechnology for cancer treatment.

William H Gmeiner1, Supratim Ghosh1.   

Abstract

Nanotechnology has the potential to increase the selectivity and potency of chemical, physical, and biological approaches for eliciting cancer cell death while minimizing collateral toxicity to nonmalignant cells. Materials on the nanoscale are increasingly being targeted to cancer cells with great specificity through both active and passive targeting. In this review, we summarize recent literature that has broken new ground in the use of nanotechnology for cancer treatment with an emphasis on targeted drug delivery.

Entities:  

Keywords:  cancer; drug-delivery; nanotechnology

Year:  2015        PMID: 26082884      PMCID: PMC4465796          DOI: 10.1515/ntrev-2013-0013

Source DB:  PubMed          Journal:  Nanotechnol Rev        ISSN: 2191-9089            Impact factor:   7.848


  127 in total

1.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy.

Authors:  Adam J Gormley; Nate Larson; Shraddha Sadekar; Ryan Robinson; Abhijit Ray; Hamidreza Ghandehari
Journal:  Nano Today       Date:  2012-05-24       Impact factor: 20.722

Review 3.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.

Authors:  Kazuo Maruyama
Journal:  Adv Drug Deliv Rev       Date:  2010-10-28       Impact factor: 15.470

4.  Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.

Authors:  Vivechana Dixit; Jeroen Van den Bossche; Debra M Sherman; David H Thompson; Ronald P Andres
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

Review 5.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

6.  Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

Authors:  Blaine J Zern; Ann-Marie Chacko; Jin Liu; Colin F Greineder; Eric R Blankemeyer; Ravi Radhakrishnan; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2013-02-08       Impact factor: 15.881

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

8.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes.

Authors:  Supratim Ghosh; Samrat Dutta; Evan Gomes; David Carroll; Ralph D'Agostino; John Olson; Martin Guthold; William H Gmeiner
Journal:  ACS Nano       Date:  2009-09-22       Impact factor: 15.881

10.  FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation.

Authors:  Anna Szlachcic; Katarzyna Pala; Malgorzata Zakrzewska; Piotr Jakimowicz; Antoni Wiedlocha; Jacek Otlewski
Journal:  Int J Nanomedicine       Date:  2012-11-29
View more
  19 in total

Review 1.  A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

Authors:  Sheila M Barros; Susan K Whitaker; Pinakin Sukthankar; L Adriana Avila; Sushanth Gudlur; Matt Warner; Eduardo I C Beltrão; John M Tomich
Journal:  Arch Biochem Biophys       Date:  2016-02-27       Impact factor: 4.013

2.  Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.

Authors:  Wenwu Xiao; Nell Suby; Kai Xiao; Tzu-Yin Lin; Nasir Al Awwad; Kit S Lam; Yuanpei Li
Journal:  J Control Release       Date:  2017-08-25       Impact factor: 9.776

Review 3.  Nanoparticle-Based Combination Therapy for Melanoma.

Authors:  Hongbo Chen; Kai Hou; Jing Yu; Le Wang; Xue Chen
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

4.  Functionalization of iron oxide nanoparticles with clove extract to induce apoptosis in MCF-7 breast cancer cells.

Authors:  T Thenmozhi
Journal:  3 Biotech       Date:  2020-02-01       Impact factor: 2.406

Review 5.  Recent Advances in Nanotechnology for the Treatment of Melanoma.

Authors:  Roberta Cassano; Massimo Cuconato; Gabriella Calviello; Simona Serini; Sonia Trombino
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

Review 6.  Potential applications of engineered nanoparticles in medicine and biology: an update.

Authors:  Gudepalya Renukaiah Rudramurthy; Mallappa Kumara Swamy
Journal:  J Biol Inorg Chem       Date:  2018-08-10       Impact factor: 3.862

7.  Comparison of cytocompatibility and anticancer properties of traditional and green chemistry-synthesized tellurium nanowires.

Authors:  Ada Vernet Crua; David Medina; Bohan Zhang; María Ujué González; Yves Huttel; José Miguel García-Martín; Jorge L Cholula-Díaz; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2019-05-03

Review 8.  Current Biochemical Applications and Future Prospects of Chlorotoxin in Cancer Diagnostics and Therapeutics.

Authors:  Sbonelo Khanyile; Priscilla Masamba; Babatunji Emmanuel Oyinloye; Londiwe Simphiwe Mbatha; Abidemi Paul Kappo
Journal:  Adv Pharm Bull       Date:  2019-10-24

9.  In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.

Authors:  Mallesh Kurakula; N Raghavendra Naveen
Journal:  Mar Drugs       Date:  2020-04-09       Impact factor: 5.118

Review 10.  Impact of Molybdenum Compounds as Anticancer Agents.

Authors:  Ayodele T Odularu; Peter A Ajibade; Johannes Z Mbese
Journal:  Bioinorg Chem Appl       Date:  2019-09-10       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.